The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

April 22, 2021

Study Completion Date

April 22, 2021

Conditions
MigraineMigraine;MenstrualContraception
Interventions
DRUG

Topiramate

"Topiramate - Participants will undergo a 6 week titrated regimen of oral topiramate to reach a maximum dose of 400mg per day:~Week 1 - topiramate PO 25mg daily Week 2 - topiramate PO 25mg twice daily Week 3 - topiramate PO 50mg twice daily Week 4 - topiramate PO 100mg twice daily Week 5 - topiramate PO 150mg twice daily Week 6 - topiramate PO 200mg twice daily"

Trial Locations (1)

80045

University of Colorado Denver, Aurora

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Colorado, Denver

OTHER

NCT03335163 - The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users | Biotech Hunter | Biotech Hunter